Unique ID issued by UMIN | UMIN000053389 |
---|---|
Receipt number | R000060884 |
Scientific Title | Development of a new diagnostic method for cardiac amyloidosis by delayed contrast-enhanced quantification of myocardium using single-energy CT. |
Date of disclosure of the study information | 2024/01/18 |
Last modified on | 2024/07/19 20:38:34 |
Development of a diagnostic method for cardiac amyloidosis by delayed contrast imaging of myocardium using CT.
Development of a diagnostic method for cardiac amyloidosis using contrast imaging of myocardium with CT.
Development of a new diagnostic method for cardiac amyloidosis by delayed contrast-enhanced quantification of myocardium using single-energy CT.
Development of a diagnostic method for cardiac amyloidosis by delayed contrast imaging using single-energy CT.
Japan |
cardiac amyloidosis
Cardiology | Radiology |
Others
NO
To develop a diagnostic method for cardiac amyloidosis similar to dual-energy CT by acquiring two images with single-energy CT.
Efficacy
Evaluation of a diagnostic method by delayed contrast-enhanced images using single energy CT in patients with cardiac amyloidosis.
Observational
20 | years-old | <= |
90 | years-old | > |
Male and Female
(1) Patients for whom a preoperative contrast CT scan for transcatheter aortic valve implantation will be performed, who can use the necessary amount of contrast media and can hold their breath for 25 to 30 seconds.
(2) Patients who are at least 20 years old and less than 90 years old at the time of obtaining consent.
(3) Patients who have been diagnosed with chronic myocardial infarction based on the diagnostic criteria of the Guidelines for the Diagnosis of Chronic Coronary Artery Disease and have imaging findings on delayed contrast-enhanced MRI images or cardiac nuclear medicine examinations (SPECT, PET), or who are suspected to have cardiac amyloidosis based on echocardiographic or electrocardiographic findings, or who are eligible for additional examinations in the future if imaging is necessary (iv) Patients who have agreed to participate in this study.
(4) Patients who have agreed to participate in this study.
(1) Patients with a heart rate of 80 or more or with arrhythmia
(2) Patients with a cardiac pacemaker
(iii) Patients who are 90 years of age or older and are considered to have difficulty holding their breath for 25-30 seconds
(iv) Patients with psychiatric disorders or psychiatric symptoms that make it difficult for them to participate in the study.
80
1st name | Hirofumi |
Middle name | |
Last name | Sekino |
Fukushima Medical University
Department of Radiology and Nuclear medicine
9601295
Hikarigaoka 1, Fukushima-Shi, Fukushima, Japan
0245471111
sekino@fmu.ac.jp
1st name | Hirofumi |
Middle name | |
Last name | Sekino |
Fukushima Medical University
Department of Radiology and Nuclear medicine
960-1295
Hikarigaoka 1, Fukushima-Shi, Fukushima, Japan
0245471111
sekino@fmu.ac.jp
Fukushima Medical University
JSPS
Japanese Governmental office
Fukushima Medical University
Hikarigaoka 1, Fukushima-Shi, Fukushima, Japan
024547111
fmu@esct.bvits.com
NO
2024 | Year | 01 | Month | 18 | Day |
Unpublished
Enrolling by invitation
2023 | Year | 12 | Month | 20 | Day |
2023 | Year | 12 | Month | 20 | Day |
2024 | Year | 01 | Month | 18 | Day |
2028 | Year | 07 | Month | 31 | Day |
none
2024 | Year | 01 | Month | 18 | Day |
2024 | Year | 07 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060884